EE200300135A - Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid - Google Patents

Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid

Info

Publication number: EE200300135A
Authority: EE; Estonia
Prior art keywords: pharmaceutical preparations; related compounds; preparations containing; tryptamine derivatives; tryptamine
Prior art date: 2000-10-03

Application number

EEP200300135A

Other languages

English (en)

Inventor

Zisapel Nava

Laudon Moshe

Original Assignee

Neurim Pharmaceuticals (1991) Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-03

Filing date

2001-09-25

Publication date

2003-08-15

2001-09-25 Application filed by Neurim Pharmaceuticals (1991) Ltd. filed Critical Neurim Pharmaceuticals (1991) Ltd.

2003-08-15 Publication of EE200300135A publication Critical patent/EE200300135A/et

2009-08-17 Publication of EE05192B1 publication Critical patent/EE05192B1/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Obesity (AREA)
Psychology (AREA)
Psychiatry (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Anesthesiology (AREA)
Emergency Medicine (AREA)
Toxicology (AREA)
Ophthalmology & Optometry (AREA)
Biochemistry (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EEP200300135A 2000-10-03 2001-09-25 Trptamiini derivaadid ja analoogsed hendid ning neid sisaldavad farmatseutilised preparaadid EE05192B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IL138825A IL138825A (en)	2000-10-03	2000-10-03	Pharmaceutical preparations containing tryptamine derivatives and similar compounds, and such new compounds
PCT/IL2001/000898 WO2002028347A2 (en)	2000-10-03	2001-09-25	Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them

Publications (2)

Publication Number	Publication Date
EE200300135A true EE200300135A (et)	2003-08-15
EE05192B1 EE05192B1 (et)	2009-08-17

Family

ID=11074694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200300135A EE05192B1 (et)	2000-10-03	2001-09-25	Trptamiini derivaadid ja analoogsed hendid ning neid sisaldavad farmatseutilised preparaadid

Country Status (39)

Country	Link
US (2)	US6780884B2 (et)
EP (1)	EP1331935B1 (et)
JP (1)	JP2004533986A (et)
KR (1)	KR100855385B1 (et)
CN (1)	CN100518735C (et)
AR (1)	AR035587A1 (et)
AT (1)	ATE409474T1 (et)
AU (1)	AU9416201A (et)
BG (1)	BG107759A (et)
BR (1)	BR0114464A (et)
CA (1)	CA2423628C (et)
CL (1)	CL2001002303A1 (et)
CR (1)	CR6968A (et)
CY (1)	CY1110417T1 (et)
CZ (1)	CZ301098B6 (et)
DE (1)	DE60136003D1 (et)
DK (1)	DK1331935T3 (et)
EA (1)	EA005918B1 (et)
EE (1)	EE05192B1 (et)
ES (1)	ES2315307T3 (et)
GT (1)	GT200100197A (et)
HN (1)	HN2001000218A (et)
HU (1)	HU227163B1 (et)
IL (1)	IL138825A (et)
IS (1)	IS2607B (et)
MX (1)	MXPA03002612A (et)
NO (1)	NO20031396D0 (et)
NZ (1)	NZ525587A (et)
PA (1)	PA8529801A1 (et)
PE (1)	PE20020411A1 (et)
PL (1)	PL365679A1 (et)
PT (1)	PT1331935E (et)
SI (1)	SI1331935T1 (et)
SK (1)	SK4042003A3 (et)
TW (1)	TWI270544B (et)
UA (1)	UA75091C2 (et)
UY (1)	UY26946A1 (et)
WO (1)	WO2002028347A2 (et)
ZA (1)	ZA200303113B (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2007515429A (ja) *	2003-12-19	2007-06-14	エリクシアーファーマシューティカルズ，インコーポレイテッド	障害を治療する方法
EP1715742A4 (en) *	2004-02-20	2009-06-17	Lifescape Biosciences Inc	COMPOSITIONS AND METHODS FOR SLEEPING
BRPI0611814A2 (pt) *	2005-06-10	2008-12-09	Bipar Sciences Inc	moduladores parp e tratamento de cÂnceres
US7622495B2 (en)	2006-10-03	2009-11-24	Neurim Pharmaceuticals (1991) Ltd.	Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
CA2729006C (en)	2007-06-29	2017-01-31	Clarencew Pty Ltd	Treatment or prophylaxis of neurological or neuropsychiatric disorders via ocular administration
US8852630B2 (en)	2008-05-13	2014-10-07	Yale University	Chimeric small molecules for the recruitment of antibodies to cancer cells
RS54428B1 (sr) *	2008-05-13	2016-04-28	Yale University	Himerični mali molekuli za regrutovanje antitela za ćelije kancera
EP2713883B1 (en)	2011-05-31	2024-07-10	Clarencew Pty Ltd.	Methods for preventing and treating motor-related neurological conditions
WO2013063492A1 (en) *	2011-10-28	2013-05-02	Board Of Regents, The University Of Texas System	Novel compositions and methods for treating cancer
CN102816103B (zh) *	2012-08-20	2014-05-07	冉瑞琼	硫化天冬氨酸修饰的退黑素衍生物及其应用
MX2018011052A (es) *	2016-03-14	2019-01-24	Somalogic Inc	Compuestos y metodos para la sintesis de fosforamidato de 5-(n-triptamina carboxamida protegida)-2'-desoxiuridina para ser incorporados en una secuencia nucleica.
CN116421600B (zh) *	2023-05-29	2024-08-23	重庆医科大学	色醇在制备治疗焦虑的药物中的应用
WO2025137730A1 (en) *	2023-12-22	2025-06-26	Alexander Shulgin Research Institute, Inc.	N-substituted tryptamines and n-substituted lysergamides and their use as therapeutic agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL79264A0 (en)	1986-06-27	1986-09-30	Univ Ramot	Tryptamine derivatives,pharmaceutical compositions containing them and their use in an assay for melatonin receptors
AUPO274596A0 (en) *	1996-10-04	1996-10-31	Armstrong, Stuart Maxwell	Method for the treatment of neurological or neuropsychiatric disorders
US6310085B1 (en) *	1997-10-03	2001-10-30	Clarencew Pty Ltd.	Method for the treatment of neurological or neuropsychiatric disorders

2000
- 2000-10-03 IL IL138825A patent/IL138825A/en not_active IP Right Cessation
2001
- 2001-09-14 TW TW090122940A patent/TWI270544B/zh not_active IP Right Cessation
- 2001-09-25 SK SK404-2003A patent/SK4042003A3/sk unknown
- 2001-09-25 EE EEP200300135A patent/EE05192B1/et not_active IP Right Cessation
- 2001-09-25 MX MXPA03002612A patent/MXPA03002612A/es active IP Right Grant
- 2001-09-25 PT PT01974651T patent/PT1331935E/pt unknown
- 2001-09-25 PL PL01365679A patent/PL365679A1/xx not_active Application Discontinuation
- 2001-09-25 UA UA2003043421A patent/UA75091C2/uk unknown
- 2001-09-25 AU AU9416201A patent/AU9416201A/xx not_active Withdrawn
- 2001-09-25 KR KR1020037004661A patent/KR100855385B1/ko not_active Expired - Fee Related
- 2001-09-25 HU HU0302616A patent/HU227163B1/hu not_active IP Right Cessation
- 2001-09-25 DE DE60136003T patent/DE60136003D1/de not_active Expired - Lifetime
- 2001-09-25 US US10/381,976 patent/US6780884B2/en not_active Expired - Fee Related
- 2001-09-25 CN CNB018168043A patent/CN100518735C/zh not_active Expired - Fee Related
- 2001-09-25 CA CA2423628A patent/CA2423628C/en not_active Expired - Fee Related
- 2001-09-25 ES ES01974651T patent/ES2315307T3/es not_active Expired - Lifetime
- 2001-09-25 WO PCT/IL2001/000898 patent/WO2002028347A2/en not_active Ceased
- 2001-09-25 EP EP01974651A patent/EP1331935B1/en not_active Expired - Lifetime
- 2001-09-25 DK DK01974651T patent/DK1331935T3/da active
- 2001-09-25 CL CL2001002303A patent/CL2001002303A1/es unknown
- 2001-09-25 CZ CZ20030940A patent/CZ301098B6/cs not_active IP Right Cessation
- 2001-09-25 AR ARP010104520A patent/AR035587A1/es unknown
- 2001-09-25 SI SI200130889T patent/SI1331935T1/sl unknown
- 2001-09-25 JP JP2002531973A patent/JP2004533986A/ja active Pending
- 2001-09-25 EA EA200300436A patent/EA005918B1/ru not_active IP Right Cessation
- 2001-09-25 NZ NZ525587A patent/NZ525587A/en unknown
- 2001-09-25 AT AT01974651T patent/ATE409474T1/de active
- 2001-09-25 BR BR0114464-2A patent/BR0114464A/pt not_active Application Discontinuation
- 2001-09-25 UY UY26946A patent/UY26946A1/es not_active Application Discontinuation
- 2001-09-26 PE PE2001000960A patent/PE20020411A1/es not_active Application Discontinuation
- 2001-09-27 GT GT200100197A patent/GT200100197A/es unknown
- 2001-10-01 PA PA20018529801A patent/PA8529801A1/es unknown
- 2001-10-02 HN HN2001000218A patent/HN2001000218A/es unknown
2003
- 2003-03-21 IS IS6752A patent/IS2607B/is unknown
- 2003-03-27 NO NO20031396A patent/NO20031396D0/no not_active Application Discontinuation
- 2003-04-23 ZA ZA200303113A patent/ZA200303113B/xx unknown
- 2003-04-24 BG BG107759A patent/BG107759A/bg unknown
- 2003-05-02 CR CR6968A patent/CR6968A/es unknown
2004
- 2004-08-20 US US10/921,823 patent/US20050020664A1/en not_active Abandoned
2008
- 2008-12-22 CY CY20081101480T patent/CY1110417T1/el unknown

Also Published As

Publication number	Publication date
PT1331935E (pt)	2009-01-19
EP1331935B1 (en)	2008-10-01
AU9416201A (en)	2002-04-15
NO20031396L (no)	2003-03-27
IS2607B (is)	2010-04-15
WO2002028347A2 (en)	2002-04-11
ZA200303113B (en)	2004-07-23
JP2004533986A (ja)	2004-11-11
DE60136003D1 (de)	2008-11-13
HUP0302616A2 (hu)	2003-11-28
SI1331935T1 (sl)	2009-04-30
CZ301098B6 (cs)	2009-11-04
CA2423628A1 (en)	2002-04-11
EE05192B1 (et)	2009-08-17
DK1331935T3 (da)	2009-02-02
US6780884B2 (en)	2004-08-24
ES2315307T3 (es)	2009-04-01
ATE409474T1 (de)	2008-10-15
HN2001000218A (es)	2002-05-09
EA005918B1 (ru)	2005-06-30
NZ525587A (en)	2005-03-24
WO2002028347A3 (en)	2002-07-04
CR6968A (es)	2004-02-25
CN100518735C (zh)	2009-07-29
BG107759A (bg)	2004-01-30
EP1331935A2 (en)	2003-08-06
GT200100197A (es)	2002-05-08
IS6752A (is)	2003-03-21
NO20031396D0 (no)	2003-03-27
MXPA03002612A (es)	2004-04-02
CY1110417T1 (el)	2015-04-29
CL2001002303A1 (es)	2010-06-25
HU227163B1 (en)	2010-09-28
PA8529801A1 (es)	2002-12-30
CA2423628C (en)	2011-04-26
TWI270544B (en)	2007-01-11
HK1074163A1 (zh)	2005-11-04
US20050020664A1 (en)	2005-01-27
BR0114464A (pt)	2004-01-20
CN1582147A (zh)	2005-02-16
UA75091C2 (en)	2006-03-15
UY26946A1 (es)	2001-11-30
IL138825A0 (en)	2001-10-31
CZ2003940A3 (cs)	2003-10-15
KR20030051689A (ko)	2003-06-25
EA200300436A1 (ru)	2003-10-30
SK4042003A3 (en)	2003-09-11
EP1331935A4 (en)	2004-12-01
IL138825A (en)	2006-06-11
KR100855385B1 (ko)	2008-09-04
AR035587A1 (es)	2004-06-16
PL365679A1 (en)	2005-01-10
US20040029950A1 (en)	2004-02-12
PE20020411A1 (es)	2002-05-16

Publication	Publication Date	Title
NO20021401D0 (no)	2002-03-20	Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20024175D0 (no)	2002-09-02	Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20030139L (no)	2003-03-13	Farmasöytiske preparater inneholdende DDS forbindelser
NO20071303L (no)	2001-07-27	Farmasoytiske preparater
EE200200409A (et)	2003-12-15	1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid
NO20020304L (no)	2002-03-21	Konserverte farmasoytiske preparater
NO992339D0 (no)	1999-05-14	Farmas°ytiske formuleringer
IS5245A (is)	1999-11-11	Lyfjablanda úr ómeprasól
EE200100431A (et)	2002-12-16	16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE200200357A (et)	2003-10-15	Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
ATE238812T1 (de)	2003-05-15	Voriconazol-enthaltende pharmazeutische zubereitungen
NO985368D0 (no)	1998-11-18	Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
FIU20000164U0 (fi)	2000-04-11	Uusi farmaseuttinen formulaatio
NO996372D0 (no)	1999-12-21	Fast farmasoeytisk preparat inneholdende benzofuanderivater
ATE332132T1 (de)	2006-07-15	Verbesserte arzneizubereitungen enthaltend ritonavir
NO20026013L (no)	2003-02-13	Medisinske preparater inneholdende propenonderivater
NO20004277D0 (no)	2000-08-25	Indolderivater og farmasøytiske sammensetninger omfattende det samme
EE200300135A (et)	2003-08-15	Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid
EE05004B1 (et)	2008-04-15	Aminotiasooli derivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid
NO992724D0 (no)	1999-06-04	Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater
DE69926012D1 (de)	2005-08-04	Arzneizubereitungen
PT1227817E (pt)	2004-11-30	Composicao farmaceutica aquosa contendo ciclesonida
DE69907735D1 (de)	2003-06-12	Melatoninderivate und diese enthaltende pharmazeutische zubereitung
AR025867A1 (es)	2002-12-18	Formulacion portasdora farmaceutica
NO20013878L (no)	2001-10-10	(1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme

Legal Events

Date	Code	Title	Description
2011-02-15	KB4A	Valid patent at the end of a year	Effective date: 20101231
2012-06-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20110925